Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ODM-207 in advanced solid tumors
NCT03035591Phase 2Completed
- Sponsor
- Orion Corporation
- Start
- Dec 2016
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ODM-207 in solid tumor, sponsored by Orion Corporation. Started Dec 2016; status: completed.
02
Drugs
ODM-207
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT03035591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03035591.